Artelo Biosciences, Inc. (ARTL) Misses Q3 EPS by 18c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q3 EPS of ($0.83), $0.18 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• KeyBanc on National Fuel Gas (NFG): 'P&S Growth an Underappreciated Hedge to Weak Natural Gas Prices'
• T. Rowe Price (TROW) PT Raised to $110 at TD Cowen